Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtyMutations(27 courses)

All specialties

Mutations

27 courses

Exon 20 Insertions - What Will be the Ideal Therapy?

STK11, KEAP and TP53 as Co-Mutations with Bad Prognosis - Is there a Predictive Role?

Resistance to KRAS Inhibitors

Targeting CEACAM5 and ROR1/ROR2 in NSCLC

RET and NTRK: The Good, The Bad, The Ugly.... and What’s Coming Up?

Exon 20 and Uncommon EGFR Sensitive Mutations

Best Approaches for First Line EGFR Mutant NSCLC

K-RAS and ERBB2 Mutation in NSCLC

ALK, ROS-1, RET and MET

EGFRex20ins, METex14 and RET in NSCLC

ALK & ROS-1: First Line & Mechanism of Resistance

EGFR PKI Resistance and K-RAS Mutations

Management of EGFR Mutant NSCLC Patients and Future Directions (excluding Resistance to EGFR TKIs)

Stage IV KRAS Mutant Lung Cancer Case

EGFR-Mutated Lung Cancers

Approach to NSCLC With Targetable Mutations (EGFR, ALK and ROS-1)

Approach to NSCLC Without Targetable Mutations

EGFR Mutations: What's Next?

Other Driver Mutations: ROS-1, RET, HER-2, MET & Exon 20 Insertions

EGFR & ALK: Where are We Now

EGFR: Common and Uncommon Mutations and What Is Next for This Patient Population

Uncommon Mutations/ Fusions: EGFRex20, RET, MET, HER2, NRG1

Dealing with EGFRex19del & L858R, ALK, and K-RasG12C Genetic Aberrations

EGFR: Common and Uncommon Mutations - What Is Next for These Patient Populations?

Common and Uncommon Mutations - What Is Next for These Patient Populations

Showing 25 of 27 courses

Contact Us

info@meccinc.com

(305) 663-1628

Powered By CMEGenius™

Privacy Policy Terms and Conditions Cancellation and Refund Policy AI Disclosure